Answers are grounded in this paper and cite their sources.
All included studies reported a negative impact of HS on patients' lives. A diverse set of disease- and non-disease-specific PRO instruments were utilized highlighting the need for more consistent use of HS-specific validated PRO instruments to assess the impact of HS on the different aspects of patients' HRQoL to allow for data to be more meaningfully interpreted and compared in real-world settings. Patients with HS need better disease management approaches that address the observed low quality of life.
No takes yet. Share an insight, caveat, or question.
Kimball et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: